$TPIV - partnership news with AZN - READY TO BREAK OUT SOON TapImmune Announces Phase 2 Ovarian Cancer Trial Study with AstraZeneca/MedImmune and Sloan Kettering Cancer Institute http://finance.yahoo.com/news/tapimmune-announces-phase-2-ovarian-131500507.html GOING HIGHER